brl 42810 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 12 patients with hematologic malignancies, we performed a prospective study to determine the effectiveness of nucleoside analogues in the pre-emptive therapy of chemotherapy-induced HBV reactivation." | 2.72 | A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. ( Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yağci, M | 2 |
| Acar, K | 2 |
| Sucak, GT | 1 |
| Aki, Z | 1 |
| Bozdayi, G | 1 |
| Haznedar, R | 1 |
1 trial available for brl 42810 and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; F | 2006 |